Clinical predictive value of naïve and memory T cells in advanced NSCLC

Currently, there is no sensitive prognostic biomarker to screen out benefit patients from the non-benefit population in advanced non-small cell lung cancer patients (aNSCLCs). The 435 aNSCLCs and 278 normal controls (NCs) were recruited. The percentages and absolute counts (AC) of circulating naïve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guan, Liu, Aqing, Yang, Yanjie, Xia, Ying, Li, Wentao, Liu, Yunhe, Zhang, Jing, Cui, Qian, Wang, Dong, Liu, Xu, Guo, Yongtie, Chen, Huayu, Yu, Jianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478592/
https://www.ncbi.nlm.nih.gov/pubmed/36119064
http://dx.doi.org/10.3389/fimmu.2022.996348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478592/
https://www.ncbi.nlm.nih.gov/pubmed/36119064
http://dx.doi.org/10.3389/fimmu.2022.996348

Ejemplares similares